Clinical Trial Update: RENABLATE-II Feasibility Study of Catheter Based Renal Denervation to Treat Resistant Hypertension - 157 [Phase 1]

View source ↗

Summary

Phase 1 feasibility trial update on catheter-based renal denervation (RENABLATE-II) for resistant hypertension; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Resistant Hypertension

Drugs mentioned

• RENABLATE-II Renal Denervation System

Snippet

Sponsor: Biosense Webster, Inc. | Conditions: Hypertension, Renal | Phase 1 | Status: COMPLETED | Results posted: 2015-12-07